The information in this section is intended for visitors outside the United States.
SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present at three investor conferences in November:
Credit Suisse 25th Annual Healthcare Conference
Jefferies London Healthcare Conference
Stifel 2016 Healthcare Conference
A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.
About Kite Pharma
Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161028005154/en/
Kite Pharma, Inc.Christine CassianoSVP, Corporate Communications & Investor Relationsccassiano@kitepharma.comorGreg MannVP, Investor Relationsgmann@kitepharma.com
Source: Kite Pharma, Inc.
News Provided by Acquire Media